Haemonetics Corp- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Haemonetics Corp 公司

Haemonetics Corporation 是一家全球医疗保健公司。该公司致力于为客户提供一系列医疗产品和解决方案，帮助他们改善患者护理并降低医疗保健成本。该公司的技术适用于各种医疗市场，包括血液和血浆成分采集、手术室和医院输血服务。该公司的血浆部门包括血浆采集设备和一次性用品、捐赠者管理软件和销售给血浆客户的支持软件解决方案。其血液中心部门制造并为客户提供全系列的自动血液采集单采解决方案。该公司的医院部门包括介入技术，包括血管闭合、传感器引导技术和食管保护产品，以及血液管理技术，包括止血管理、细胞回收和输血管理产品。

公司简介

公司代码HAE

公司名称Haemonetics Corp

上市日期Oct 17, 1979

CEOMr. Christopher A. Simon

员工数量3023

证券类型Ordinary Share

年结日Oct 17

公司地址125 Summer Street

城市BOSTON

上市交易所NYSE Consolidated

国家United States of America

邮编02110

电话17818487100

网址https://www.haemonetics.com

公司代码HAE

上市日期Oct 17, 1979

CEOMr. Christopher A. Simon

公司高管

名称

名称/职务

职务

持股

持股变动

Ms. Laurie A. Miller

Chief Human Resources Officer, Senior Vice President

28.24K

+12.76%

Mr. Charles J. Dockendorff, CPA

Independent Director

25.04K

+12.05%

Mr. Robert E. Abernathy

Independent Director

24.98K

+12.08%

Dr. Mark W. Kroll, Ph.D.

Independent Director

23.36K

+13.03%

Ms. Michelle L. Basil, J.D.

Executive Vice President, General Counsel

19.69K

+2.11%

Ms. Ellen M. Zane

Independent Chairman of the Board

19.37K

+16.15%

Mr. Michael J. Coyle

Independent Director

15.39K

+21.20%

Ms. Diane M. Bryant

Independent Director

7.13K

+60.75%

Mr. Roy Galvin

Executive Vice President, Chief Commercial Officer

3.39K

--

Mr. Frank W. Chan

Chief Operating Officer, Executive Vice President

--

名称

名称/职务

职务

持股

持股变动

Ms. Laurie A. Miller

Chief Human Resources Officer, Senior Vice President

28.24K

+12.76%

Mr. Charles J. Dockendorff, CPA

Independent Director

25.04K

+12.05%

Mr. Robert E. Abernathy

Independent Director

24.98K

+12.08%

Dr. Mark W. Kroll, Ph.D.

Independent Director

23.36K

+13.03%

Ms. Michelle L. Basil, J.D.

Executive Vice President, General Counsel

19.69K

+2.11%

Ms. Ellen M. Zane

Independent Chairman of the Board

19.37K

+16.15%

收入明细

单位: USD更新时间: 7月6日周日

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2021

FY2020

FY2019

暂无数据

地区USD

名称

营收

占比

United States

1.01B

74.29%

Europe

175.66M

12.91%

Asia

92.31M

6.78%

Japan

62.41M

4.59%

other

19.54M

1.44%

业务

地区

暂无数据

股东统计

更新时间: 8月27日周三

持股股东

股东类型

持股股东

占比

BlackRock Institutional Trust Company, N.A.

11.56%

The Vanguard Group, Inc.

10.26%

Neuberger Berman, LLC

8.88%

Wellington Management Company, LLP

4.46%

State Street Global Advisors (US)

3.91%

其他

60.94%

持股股东

占比

BlackRock Institutional Trust Company, N.A.

11.56%

The Vanguard Group, Inc.

10.26%

Neuberger Berman, LLC

8.88%

Wellington Management Company, LLP

4.46%

State Street Global Advisors (US)

3.91%

其他

60.94%

股东类型

持股股东

占比

Investment Advisor

52.55%

Investment Advisor/Hedge Fund

49.82%

Hedge Fund

5.32%

Research Firm

4.12%

Bank and Trust

1.39%

Pension Fund

1.35%

Individual Investor

1.19%

Sovereign Wealth Fund

1.11%

Insurance Company

0.04%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

700

57.31M

118.95%

-4.19M

2025Q1

723

57.94M

120.44%

-3.07M

2024Q4

701

58.48M

116.40%

-1.44M

2024Q3

689

57.60M

112.60%

-1.51M

2024Q2

668

57.60M

113.31%

+3.07M

2024Q1

655

52.49M

103.35%

-1.26M

2023Q4

647

51.85M

102.19%

-3.31M

2023Q3

657

52.00M

102.54%

-4.11M

2023Q2

656

51.75M

102.38%

-4.68M

2023Q1

715

51.58M

102.24%

-8.44M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

BlackRock Institutional Trust Company, N.A.

5.67M

11.79%

+31.09K

+0.55%

Mar 31, 2025

The Vanguard Group, Inc.

5.09M

10.59%

-80.50K

-1.56%

Mar 31, 2025

Neuberger Berman, LLC

4.35M

9.05%

-70.98K

-1.61%

Mar 31, 2025

Wellington Management Company, LLP

2.62M

5.46%

-1.32M

-33.38%

Mar 31, 2025

State Street Global Advisors (US)

1.92M

3.99%

-28.97K

-1.49%

Mar 31, 2025

River Road Asset Management, LLC

1.40M

2.9%

+1.04M

+295.76%

Mar 31, 2025

T. Rowe Price Investment Management, Inc.

2.20M

4.57%

-358.25K

-14.03%

Mar 31, 2025

Royce Investment Partners

1.16M

2.42%

+8.03K

+0.70%

Mar 31, 2025

Geode Capital Management, L.L.C.

1.22M

2.54%

+40.32K

+3.41%

Mar 31, 2025

Capital Research Global Investors

1.58M

3.28%

-2.66M

-62.79%

Mar 31, 2025

持股ETF

更新时间: 9月6日周六

机构名称

占比

Harbor Human Capital Factor US Small Cap ETF

1.78%

SPDR S&P Health Care Equipment ETF

1.45%

First Trust Small Cap Growth AlphaDEX Fund

0.28%

Fidelity Small-Mid Multifactor ETF

0.15%

Global X Russell 2000 ETF

0.15%

Vanguard S&P Mid-Cap 400 Growth Index Fund

0.14%

Invesco Dynamic Buyback Achievers ETF

0.12%

Nuveen ESG Small-Cap ETF

0.11%

Vanguard S&P Mid-Cap 400 Value Index Fund

0.11%

SPDR S&P 400 Mid Cap Growth ETF

0.1%

Harbor Human Capital Factor US Small Cap ETF

占比1.78%

SPDR S&P Health Care Equipment ETF

占比1.45%

First Trust Small Cap Growth AlphaDEX Fund

占比0.28%

Fidelity Small-Mid Multifactor ETF

占比0.15%

Global X Russell 2000 ETF

占比0.15%

Vanguard S&P Mid-Cap 400 Growth Index Fund

占比0.14%

Invesco Dynamic Buyback Achievers ETF

占比0.12%

Nuveen ESG Small-Cap ETF

占比0.11%

Vanguard S&P Mid-Cap 400 Value Index Fund

占比0.11%

SPDR S&P 400 Mid Cap Growth ETF

占比0.1%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

Haemonetics Corp

50.600USD

Haemonetics Corp

50.600

概览

公司

财务

分析